As Turing & Valeant Cast A Negative Shadow, Larry Robbins Fumes

While the healthcare sector has experienced a setback recently, having “become short-term auto-correlated to the downside,” Hedge Fund titan Larry Robbins of Glenview Capital frets about the recent problems that have befallen the healthcare sector, which has been especially hard hit during the recent market downturn. Using uncommonly strong language in an investor letter, he appeared to cast a dubious eye towards quick to profit pharmaceutical firms who have raised prices so egregiously that it caused a harsh political focus to taint an entire industry. In an investor letter reviewed by ValueWalk, he also cast a wary eye on the accounting and business practices of a "high-profile consolidator" in the pharmaceutical sector.

Nonetheless Robbins thinks his investment theses regarding the overall healthcare sector is positive and his correlation strategy of using different sub-categories within the industry remains valid going forward.

Larry Robbins appears to target Martin Shkreli as healthcare stocks plummet amid political controversy.

As previously reported in ValueWalk, Larry Robbins has experienced a “disappointing” results over the past three months. While most stocks suffered from late August to September, one sector has particularly been hard hit. The healthcare equity exposure maintained inside the Glenview portfolio suffered punitive losses as many of the stock sub categories correlated to one during the stock market turbulence experienced earlier this year.

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible


Saved Articles
X
TextTExtLInkTextTExtLInk

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

Congrats! Are you a smart person?

We have an exclusive targeted & limited time offer for being a sophisticated and loyal reader.

ValueWalkPremium is a website and newsletter on the latest industry news much of which is not in the public domain and obtained via our sources.

We also have 10 years of resources on how to use this information to better your investment process.

Sign up for  today and get our exclusive content for 40% off. This is our second biggest discount ever!!

Use coupon code VIP20 or click on the button below

Limited time offer only ENDS 2/29/2019 or after next 25 subscribers take advantage whichever comes first – please do not share this discount with others

 

0